Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the National Medical Products Administration (NMPA) ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...

The company has received approval from the United States Food and Drug Administration (USFDA) for its invention Enmetaobactam, a Beta Lactamase Inhibitor. According to the company, the USFDA ...

Master effective recall management with the two day FDA Recalls Masterclass course. Understand FDA recall authority, develop effective recall strategies, and improve compliance. Learn to identify root ...